Merle G. Paule
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Merle G. Paule has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
E. Jon Popke
Behavioral Toxicology Laboratory, Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, Arkansas, U.S.A.
3 shared publicationsJohn J. Chelonis
3 shared publicationsRichard R. Allen
Peak Statistical Services, 5691 Northwood Drive, Evergreen, Colorado, U.S.A.
3 shared publicationsEdwin Pearson
Safety Assessment, AstraZeneca Charnwood, Bakewell Road, Loughborough, Leicester, England
2 shared publicationsJohn J Chelonis
2 shared publicationsMichael P. Gillam
Behavioral Toxicology Laboratory, Division of Neurotoxicology, HFT‐132, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, Arkansas, 72079‐9502, USA
2 shared publications
Latest Publications
- 31 December 2006
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 28 (6) , 711
BTS Student Travel Award Winner Effects of prenatal cocaine exposure in DMTS task reversal on monkeys
- 31 December 2006
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 28 (6) , 711
BTS Student Travel Award Winner Effects of prenatal cocaine exposure in DMTS task reversal on monkeys
- 31 December 2006
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 28 (6) , 708
Effects of chronic low-dose acrylamide exposure on progressive ratio performance in rats
- 31 December 2006
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 28 (6) , 708
Effects of chronic low-dose acrylamide exposure on progressive ratio performance in rats
- 1 January 2005
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 10 (1-3) , 2240-9
Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans
This review of our work presents three specific examples of how nonhuman primates (rhesus monkeys, Macaca mulatta) have been used to study the effects of chronic drug exposures on brain function during different stages of development. In all cases, exposure levels similar to those experienced by humans were employed and the focus was on long-term--not acute--effects. In the case of the marijuana studies, exposures occurred during the adolescent period; for the cocaine studies, exposures occurred in binge-like fashion entirely before birth (in utero); and for the remacemide studies, exposures occurred daily in juveniles, prior to adolescence. An automated battery of behavioral tasks, the National Center for Toxicological Research Operant Test Battery (NCTR OTB), designed to assess aspects of motivation, visual discrimination, time perception, short-term memory, and learning, was used to monitor treatment effects. Chronic marijuana smoke exposure resulted in an 'amotivational' syndrome--even in weekend-only smokers--that resolved within three months of exposure cessation. In utero cocaine exposure was shown to cause behavioral rigidity or lack of plasticity as evidenced by the difficulty of subjects to adjust to rules changes for some OTB tasks. These effects were seen in adult subjects suggesting that the effects of gestational cocaine exposure are long-term or permanent. In addition, animals exposed to cocaine in utero were less sensitive to the behaviorally-disrupting effects of cocaine as adults. Remacemide caused profound and long-lasting, perhaps permanent, changes in learning task performance and because performance of this same task by children is significantly correlated with traditional measures of intelligence (IQ), these data suggest that such treatment may provide a valuable model of chemically-induced mental retardation.
- 1 January 2005
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 10 (1-3) , 2240-9
Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans
This review of our work presents three specific examples of how nonhuman primates (rhesus monkeys, Macaca mulatta) have been used to study the effects of chronic drug exposures on brain function during different stages of development. In all cases, exposure levels similar to those experienced by humans were employed and the focus was on long-term--not acute--effects. In the case of the marijuana studies, exposures occurred during the adolescent period; for the cocaine studies, exposures occurred in binge-like fashion entirely before birth (in utero); and for the remacemide studies, exposures occurred daily in juveniles, prior to adolescence. An automated battery of behavioral tasks, the National Center for Toxicological Research Operant Test Battery (NCTR OTB), designed to assess aspects of motivation, visual discrimination, time perception, short-term memory, and learning, was used to monitor treatment effects. Chronic marijuana smoke exposure resulted in an 'amotivational' syndrome--even in weekend-only smokers--that resolved within three months of exposure cessation. In utero cocaine exposure was shown to cause behavioral rigidity or lack of plasticity as evidenced by the difficulty of subjects to adjust to rules changes for some OTB tasks. These effects were seen in adult subjects suggesting that the effects of gestational cocaine exposure are long-term or permanent. In addition, animals exposed to cocaine in utero were less sensitive to the behaviorally-disrupting effects of cocaine as adults. Remacemide caused profound and long-lasting, perhaps permanent, changes in learning task performance and because performance of this same task by children is significantly correlated with traditional measures of intelligence (IQ), these data suggest that such treatment may provide a valuable model of chemically-induced mental retardation.
- 1 November 2004
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 26 (6) , 825-837
Effects of drug countermeasures for space motion sickness on working memory in humans
- 1 November 2004
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 26 (6) , 825-837
Effects of drug countermeasures for space motion sickness on working memory in humans
- 1 May 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 993 (1) , 116-122
Chronic Exposure to NMDA Receptor and Sodium Channel Blockers during Development in Monkeys and Rats
Abstract:The effects of chronic administration of MK‐801 (NMDA‐receptor antagonist) and remacemide (sodium channel blocker) on monkey learning of several brain function tasks was assessed in juveniles (nine months old). Low (LO) and high (HI) doses of both drugs were given orally each day for 18 months. There were no adverse effects of any treatment on tests of short‐term memory or motivation. HI doses of both MK‐801 and remacemide delayed acquisition of a visual discrimination task (the remacemide effect was much greater). HI doses of remacemide alone severely disrupted learning task acquisition and this effect lasted for several months after dosing. Thus, in monkeys, chronic blockade of NMDA receptors is relatively well tolerated, whereas blockade of sodium channels (perhaps in conjunction with NMDA receptor blockade) has long‐term—perhaps permanent—consequences. To further explore the roles of NMDA receptors and sodium channels in these effects, MK‐801, phenytoin (sodium channel blocker), or both were administered to rats and the acquisition of tasks similar to those used in the monkey study were assessed. Dosing began at weaning and continued for nine months. Throughout the study, HI MK‐801 subjects exhibited impaired performance in all tasks. Some effects of MK‐801 were blocked completely by phenytoin. In the rat, blockade of sodium channels was well tolerated but blockade of NMDA receptors had significant and long‐term (permanent?) adverse consequences. These data contrast markedly with those obtained for the monkey and suggest, at least for some drug classes, that the rat might not be a good predictor of effects in primates.
- 1 May 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 993 (1) , 116-122
Chronic Exposure to NMDA Receptor and Sodium Channel Blockers during Development in Monkeys and Rats
Abstract:The effects of chronic administration of MK‐801 (NMDA‐receptor antagonist) and remacemide (sodium channel blocker) on monkey learning of several brain function tasks was assessed in juveniles (nine months old). Low (LO) and high (HI) doses of both drugs were given orally each day for 18 months. There were no adverse effects of any treatment on tests of short‐term memory or motivation. HI doses of both MK‐801 and remacemide delayed acquisition of a visual discrimination task (the remacemide effect was much greater). HI doses of remacemide alone severely disrupted learning task acquisition and this effect lasted for several months after dosing. Thus, in monkeys, chronic blockade of NMDA receptors is relatively well tolerated, whereas blockade of sodium channels (perhaps in conjunction with NMDA receptor blockade) has long‐term—perhaps permanent—consequences. To further explore the roles of NMDA receptors and sodium channels in these effects, MK‐801, phenytoin (sodium channel blocker), or both were administered to rats and the acquisition of tasks similar to those used in the monkey study were assessed. Dosing began at weaning and continued for nine months. Throughout the study, HI MK‐801 subjects exhibited impaired performance in all tasks. Some effects of MK‐801 were blocked completely by phenytoin. In the rat, blockade of sodium channels was well tolerated but blockade of NMDA receptors had significant and long‐term (permanent?) adverse consequences. These data contrast markedly with those obtained for the monkey and suggest, at least for some drug classes, that the rat might not be a good predictor of effects in primates.
- 1 September 2000
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 22 (5) , 631-651
Attention deficit/hyperactivity disorder: characteristics, interventions and models
- 1 September 2000
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 22 (5) , 631-651
Attention deficit/hyperactivity disorder: characteristics, interventions and models
- 1 September 2000
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 914 (1) , 412-417
Effects of Chronicin UteroExposure to Cocaine on Behavioral Adaptability in Rhesus Monkey Offspring When Examined in Adulthood
- 1 September 2000
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 914 (1) , 412-417
Effects of Chronicin UteroExposure to Cocaine on Behavioral Adaptability in Rhesus Monkey Offspring When Examined in Adulthood
- 1 September 1999
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 21 (5) , 491-502
Conference
- 1 September 1999
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 21 (5) , 491-502
Conference